Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: A systematic scoping review

GD Chauke, O Nakwafila, B Chibi, B Sartorius… - Heliyon, 2022 - cell.com
Background Poor medication adherence among patients with Chronic Diseases is one of
the significant health problems globally. Despite this, evidence on chronic medication …

True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: a meta-analysis

D Vukadinović, D Lavall, AN Vukadinović, B Pitt… - American Heart …, 2017 - Elsevier
Background Mineralocorticoid receptor antagonists (MRA) improve survival in heart failure
with reduced ejection fraction but are often underused, mostly due to concerns of …

Burden of heart failure in Flemish general practices: a registry-based study in the Intego database

M Smeets, B Vaes, P Mamouris, M Van Den Akker… - BMJ open, 2019 - bmjopen.bmj.com
Objectives To assess the prevalence and incidence of heart failure (HF) stages A to C/D and
their evolution over a 16-year period. Additionally, trends in comorbidities and …

Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial

M Packer - European Heart Journal, 2022 - academic.oup.com
Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial
| European Heart Journal | Oxford Academic Skip to Main Content Advertisement intended for …

Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction

SJ Greene, X Tan, YC Yeh, M Bernauer, O Zaidi… - Heart Failure …, 2022 - Springer
In clinical practice, many patients with heart failure with reduced ejection fraction (HFrEF)
are either not prescribed guideline-directed medical therapies for which they are eligible or …

Adherence to guidelines in patients with chronic heart failure in primary health care

M Giezeman, M Arne, K Theander - Scandinavian journal of …, 2017 - Taylor & Francis
Objective: To describe adherence to international guidelines for chronic heart failure (CHF)
management concerning diagnostics, pharmacological treatment and self-care behaviour in …

Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation–Results from the German EuroAspire IV cohort

C Morbach, M Wagner, S Güntner, C Malsch… - BMC cardiovascular …, 2017 - Springer
Background Adherence to pharmacotherapeutic treatment guidelines in patients with heart
failure (HF) is of major prognostic importance, but thorough implementation of guidelines in …

[PDF][PDF] Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Behandlung der akuten und chronischen Herzinsuffizienz

U Laufs, SD Anker, V Falk, B Pieske, S Baldus… - Die …, 2017 - leitlinien.dgk.org
Die Patienten in den 3 Subgruppen der chronischen Herzinsuffizienz unterscheiden sich
bezüglich der klinischen Präsentation, Ätiologie und den Begleiterkrankungen. Während …

Association between hypo-and hyperkalemia and outcome in acute heart failure patients: the role of medications

M Legrand, PO Ludes, Z Massy, P Rossignol… - Clinical Research in …, 2018 - Springer
Background The interaction between chronic medications on admission and the association
between serum potassium level and outcome in patients with acute heart failure (AHF) are …

BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure

O Miro, C Müller, FJ Martin-Sanchez, H Bueno… - Clinical Research in …, 2016 - Springer
Objective To evaluate the effects of discontinuing chronic beta-blocker (BB) treatment on
short-term outcome in patients with chronic heart failure (CHF) during acute …